Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

BofA raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $567 from $555 and keeps a Buy rating on the shares. After having ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

Nuage Therapeutics, a biotech company creating transformational precision therapies, has appointed Stuart Hughes as CEO and ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

CBSE has introduced key reforms for the 2025-26 session, allowing basic calculators in Class 12 accountancy exams and launching digital evaluation. The move aims to ease cognitive load and align ...

Potbelly (NASDAQ:PBPB – Get Free Report)‘s stock had its “market perform” rating reissued by stock analysts at William Blair in a note issued to investors on Thursday,RTT News reports.

Our car loan calculator estimates a monthly car payment and total loan cost based on vehicle price, interest rate and loan length. Try different calculator scenarios to determine the best auto ...

Read Our Latest Analysis on GLRE Greenlight Capital Re Stock Performance GLRE opened at $13.22 on Monday. The firm has a market cap of $456.94 million, a P/E ratio of 5.25 and a beta of 0.86. The ...